October 24 - 27, 2024


This activity has been approved for 22.25 AMA PRA Category 1 Credit(s)™

Registration Details

About the Symposium

The 26th Annual Lynn Sage Breast Cancer Symposium
will be held in person in Chicago!

Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium will provide 3.5 days of presentations and interactive Q&A sessions in downtown Chicago this October.

For 26 years, this multidisciplinary CME program has provided the latest information regarding cutting-edge technology and approaches in the management of breast cancer from leading national and international medical, surgical, and radiation oncologists.This year's symposium will include a superb line-up of internationally recognized faculty who will not only present the latest research findings, but will also be available for real-time interaction following their presentations. The symposium will focus on the close cooperation required for effective multidisciplinary management of patients with breast cancer.

This in-person symposium will offer:

  • 3.5 days of in-person presentations and Q&A with over 30 international breast cancer experts
  • Exhibit hall with pharmaceutical companies
  • Online access to presentation slides in PDF format (through November 30)
  • Continuing education credits & MOC available
  • Catered breakfast, break refreshments, and a reception. Lunch available for purchase Thursday through Saturday.

    *Please note this year's symposium will take place fully in person in Chicago.

Learn more about the symposium by watching this video:

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University

Monica Morrow, MD
Memorial Sloan Kettering Cancer Center
Scientific Planning Committee Members

Nora Hansen, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Kalliopi Siziopikou, MD, PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Jonathan Strauss, MD, MBA
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Chicago cityscape


  • Issues in Survivorship
  • Breast Pathology for the Non-Pathologist
  • Imaging & Risk
  • Controversies in Hormone Receptor Positive Breast Cancer
  • Factors Informing Treatment and Management of Early-Stage Disease
  • Tailoring Local Therapy
  • Questions, Controversies and Future Directions
Full Agenda »


Get information about registration and the latest news by subscribing to our email list.


Please join the conversation on Twitter before, during and after the conference by connecting with us @LurieCancer, and using the hashtag #LSBC24

© 2024 Robert H. Lurie Comprehensive Cancer Center